Vezicle™ Liposomal Vitamin C Powder 70%
Single-active liposomal powder designed for moisture sensitivity, matrix interaction and formulation dispersion. 70% vitamin C; immediate / non-modified.
For business buyers. Technical documentation is available on request.
How the sample programme worksProduct information
Vezicle™ Liposomal Vitamin C Powder 70% — technical specification and documentation
Review the key specifications at a glance, then expand only the sections you need.
Single-active liposomal powder designed for moisture sensitivity, matrix interaction and formulation dispersion. 70% vitamin C; immediate / non-modified.
Liposomal Vitamin C Powder 70% supplies L-ascorbic acid (vitamin C) in a characterised phospholipid vesicle powder. It is intended as an independent formulation module for professional B2B use. Product-specific identity, assay, physical, microbiological, contaminant and stability controls are defined in the finished-product specification and verified by batch CoA.
What is Liposomal Vitamin C Powder 70%?
Liposomal Vitamin C Powder 70% supplies L-ascorbic acid (vitamin C) at 70% vitamin C in a characterised phospholipid vesicle powder; its release behaviour is Immediate / non-modified.
| Product ID / order SKU | NG-LIP-005 |
|---|---|
| Technology | Liposomal Delivery |
| Product type | Liposomal Powder |
| Current status | Qualified / In stock |
| Active / marker | L-ascorbic acid (vitamin C) |
| Assay / loading | 70% vitamin C |
| Delivery system | characterised phospholipid vesicle powder |
| Release type | Immediate / non-modified |
| Evaluation sample | 50 g — €30 ex VAT |
| Stocked MOQ | 1 kg |
| Pack sizes | 1 kg; 5 kg; 25 kg |
| Standard lead time | 3–5 business days if in stock |
What is the technical specification?
The key public specification is 70% vitamin C with Immediate / non-modified release behaviour; batch acceptance follows the approved product-specific specification and analytical method.
| Active ingredient | Vitamin C |
|---|---|
| Chemical / nutrient form | L-ascorbic acid (vitamin C) |
| Assay / loading | 70% vitamin C |
| Assay method | Approved product-specific analytical method |
| Carrier / wall material | Food-grade phospholipid delivery system and powder carrier |
| Delivery system | characterised phospholipid vesicle powder |
| Release behaviour | Immediate / non-modified |
| Particle size d10 | See characterisation data |
| Particle size d50 | See characterisation data |
| Particle size d90 | See characterisation data |
| Mesh range | Per specification |
| Bulk density | Per specification |
| Tapped density | Per specification |
| Moisture / loss on drying | Per specification |
| Water activity | Per specification |
| Solubility | Product-specific; see TDS |
| Dispersibility | Product-specific; see TDS |
| Flowability | Per finished-product specification |
| Appearance / colour | Product-specific; see TDS |
| Odour | Product-specific; see TDS |
| Taste | Product-specific; see TDS |
| pH | Not applicable unless specified |
| Microbiological limits | Per finished-product microbiological specification |
| Heavy-metals limits | Per finished-product heavy-metals specification |
| Residual solvents | Complies with finished-product specification |
| Oxidation markers | Product-specific oxidation or degradation markers per finished specification |
| Other critical specification | Liposomal structural characterisation after reconstitution |
| Shelf life | Per current stability documentation |
What is the public composition?
The public composition identifies Vitamin C with a Food-grade phospholipid delivery system and powder carrier; exact proprietary excipient ratios and supplier details remain controlled.
| Component | Function | Public composition information |
|---|---|---|
| Vitamin C | Active ingredient | Product-specific qualified source; 70% vitamin C; Finished-product specification |
| Food-grade phospholipid delivery system | Liposomal vesicle-forming system | Qualified food-grade source; q.s.; Controlled composition; exact proprietary composition is confidential |
| Food-grade powder carrier / protective matrix | Powder formation and physical stability | Qualified food-grade source; q.s. to 100%; Controlled composition; exact proprietary composition is confidential |
Country of origin is stated in the controlled Country of Origin Statement. Supplier and manufacturing-site information are not published.
Which formulation problem does this ingredient address?
A characterised phospholipid vesicle system supports moisture sensitivity, matrix interaction and formulation dispersion while keeping the ingredient as a single-active, immediate/non-modified-release powder.
- Characterised liposomal structure
- single-active format
- dry-powder handling
- immediate/non-modified release.
Which applications are the best fit?
This ingredient is best suited to capsules, tablets, sachets and premixes.
How should formulators process and evaluate it?
- Pre-disperse if required by the dosage form. Avoid prolonged exposure to heat, moisture, strong oxidants or extreme pH. Confirm process compatibility in the final matrix.
- Assess compatibility with minerals, strong oxidants, surfactants and high-temperature or extreme-pH processes.
- Confirm process compatibility, uniformity, stability and performance in the final matrix.
How is performance verified?
Performance is verified using approved product-specific methods and the controlled evidence listed below.
| Test / study | Result summary | Evidence |
|---|---|---|
| Identity and assay confirmation | Conforms to approved specification | Current commercial batch; Batch CoA |
| Liposomal structural characterisation | Characterised phospholipid vesicle system; report available | Representative batch; Liposomal Characterisation Data |
| Stability / shelf-life support | Meets approved stability criteria through the documented period | Representative stability batches; Stability Documentation |
How should it be stored and handled?
Store tightly closed in original packaging in a cool, dry place, protected from heat, moisture and direct light. Free-flowing powder with product-specific colour and odour; see TDS and batch CoA.
Which technical and quality documents are available?
The following workbook-listed documents are available and customer-shareable. Controlled composition, characterisation or performance details may require an NDA where specified.
- Technical Data Sheet (TDS)
- Finished Product Specification
- Batch Certificate of Analysis (CoA)
- Safety Data Sheet (SDS)
- Allergen Statement
- GMO Statement
- Irradiation Statement
- BSE/TSE Statement
- Stability Documentation
- Composition / Ingredient Information
- Storage & Handling Information
- Microbiological Specification
- Heavy Metals Specification
- Country of Origin Statement
- Manufacturing / Quality Certificate
- Liposomal Characterisation Data
What must buyers confirm for regulatory and intended use?
Regulatory suitability depends on the intended use, dose and target market; the customer must confirm finished-product compliance.
| Target market | European Union / EEA |
|---|---|
| Intended use | Food supplements and professional formulation use; final suitability depends on dose and application |
| Ingredient legal status | Product-specific legal-status assessment available; customer must verify intended use and national requirements |
| Novel food review | Product-specific novel-food assessment available |
| Carrier / additive compliance | All carriers, wall materials and coating components reviewed for the intended product scope |
| Maximum / recommended use level | Set by customer formulation, applicable law and product-specific technical guidance |
| Label declaration | Vitamin C |
| Allergen declaration | Declare according to the current product-specific allergen statement |
| Origin declaration | See Country of Origin Statement |
| Nutrition / health claim relevance | Finished-product nutrition or health claims are the customer’s responsibility |
| Technical claim / statement | Characterised liposomal powder supporting dispersion and formulation handling. |
| Evidence supporting statement | TDS, specification, stability and liposomal characterisation data |
| Medicinal / disease wording check | Passed: no medicinal or disease-treatment wording |
| Regulatory approval status | Ready for product-specific website approval |
How can B2B buyers evaluate and order it?
- Evaluation sample: 50 g — €30 ex VAT.
- Credited against first commercial order within 12 months
- Stocked MOQ: 1 kg.
- Standard formats: 1 kg; 5 kg; 25 kg.
- Standard lead time: 3–5 business days if in stock.
- Custom strength available: Yes, subject to feasibility.
- Custom release available: No modified-release customisation in this platform.
- Private label / custom pack: Custom pack by quotation.
- Commercial terms confirmed by quotation.
What does NexaGens not claim?
No medicinal, disease-treatment or finished-product health claim is made. Liposomal terminology applies to the characterised supplied ingredient; performance in a finished product depends on formulation and processing. Finished-product classification, dose, permitted use, label declarations, nutrition or health claims and market compliance remain the customer’s responsibility.
Frequently asked questions
What documentation is available?
TDS, finished-product specification, batch CoA, SDS and the product-specific quality package are available. Liposomal characterisation data support the structural terminology.
Can this product be combined with other ingredients?
Yes. This product may be combined with other independent NexaGens formulation modules after compatibility and finished-product validation.
What is the release format?
The release format is immediate / non-modified.
For professional B2B food, food-supplement and formulation use only. Not for direct consumer use.
Need the controlled document package?
Request the current technical, quality, stability and compliance documents for this ingredient.
Related formulation guides
Review the formulation challenges most relevant to this ingredient before requesting evaluation material or documentation.
View all liposomal ingredients